Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

102.36
+0.33000.32%
Pre-market: 102.360.00000.00%04:01 EDT
Volume:5.23M
Turnover:536.59M
Market Cap:177.99B
PE:33.12
High:103.30
Open:101.89
Low:101.50
Close:102.03
52wk High:137.49
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:0.69
T/O Rate:0.31%
Dividend:2.48
Dividend Rate:2.42%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.48
PE(LYR):27.44

Loading ...

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 04

Abbott Laboratories Stock Rises Monday, Still Underperforms Market

Dow Jones
·
Aug 04

Abitare In to Exit Borsa Italiana’s STAR Segment but Remain on Euronext Milan

TIPRANKS
·
Aug 04

Texas Governor Abbott directs comprehensive data center audit

TIPRANKS
·
Aug 04

Movement Alert|Abbott Laboratories Rises 3.21% in Regular Trading, FDA Approval of Colorectal Cancer Blood Screening Test Continues to Boost Shares

Market Focus
·
Aug 03

Perrigo Co. PLC Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 01

Abitare In closes €141 million project sale and seeks exit from STAR segment

TIPRANKS
·
Jul 31

Abbott Laboratories Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 31

3 ‘Strong Buy’ Dividend Aristocrat Stocks to Power Your Cash Flow, 7/30/26

TIPRANKS
·
Jul 31

Movement Alert|Abbott Laboratories Falls 3.08% in Regular Trading, Multiple Banks Cut Target Prices Triggering Pullback Pressure

Market Focus
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Laboratories Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Abbott Labs is Maintained at Buy by UBS

Dow Jones
·
Jul 29

Movement Alert|Abbott Laboratories Rises 3.07% in Regular Trading, FDA Approves Its Exclusive Colorectal Cancer Blood Screening Test

Market Focus
·
Jul 28

Abbott price target lowered to $125 from $135 at UBS

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating

MT Newswires Live
·
Jul 28

Abitare In Publishes 2025 Sustainability Report, Underscoring Urban Regeneration Strategy

TIPRANKS
·
Jul 28